Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride boosts immune cells that suppress T-cells, possibly helping with immune disorders but may increase cancer risk.

Adriamycin and ifosfamide together work best for advanced soft tissue sarcomas.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Fibroblasts are crucial in scar formation and wound healing, with potential therapies aiming for scarless healing.

Certain microRNAs might help identify and understand Frontal Fibrosing Alopecia.

Mast cells might contribute to hair loss by causing skin thickening.

Frontal Fibrosing Alopecia is a type of hair loss that mainly affects postmenopausal women, has unclear causes, and lacks evidence-based treatments.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

A rare eyelid tumor was successfully diagnosed and removed, highlighting the need for careful examination.

Monilethrix causes brittle hair and hair loss, and it runs in families.

Scalp biopsies are crucial for diagnosing hair loss causes in cutaneous lymphoma patients.

Lupus and frontal fibrosing alopecia may share a common cause.

Mycophenolate mofetil is a good alternative for autoimmune hepatitis patients who can't tolerate azathioprine.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

Mogamulizumab treatment in Sézary syndrome may cause skin issues and hair loss but can lead to a complete response.

Recognizing and treating overlap syndrome in connective tissue diseases is crucial.

Frontal fibrosing alopecia can sometimes look like syphilitic hair loss.

Frontal fibrosing alopecia causes hairline recession and eyebrow loss in postmenopausal women.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Sorafenib causes skin reactions by increasing the number and activity of skin mast cells.

The conclusion is that CD90 is not a specific marker for fibroblast subtypes and better methods are needed to identify them.

Chemotherapy reduces splenic melanin in mice.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Perifollicular fibrosis hinders hair regrowth in androgenetic alopecia, and new treatments targeting fibrosis are needed.

HPH-15, a new compound, effectively reduces skin fibrosis in experiments without causing harm.

Activating autophagy might reverse skin fibrosis.

Fibroblast spheres can form stem cells, but marker distribution needs more study.

Sorafenib can cause a unique skin reaction.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.